Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003470054 | SCV004191938 | uncertain significance | Pheochromocytoma | 2023-08-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004364776 | SCV005018641 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-03-09 | criteria provided, single submitter | clinical testing | The p.D119E variant (also known as c.357C>A), located in coding exon 5 of the MAX gene, results from a C to A substitution at nucleotide position 357. The aspartic acid at codon 119 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear. |